What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases. (Q34619162)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Jens Kuhle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

English

0 references

publication date

27 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Medical Diagnostics

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

333-346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Guillain-Barre syndrome in Taiwan: a clinical study of 167 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Assessment of current diagnostic criteria for Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Diagnostic and classification criteria for the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Immunotherapy for Guillain-Barre syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

The distribution of tau in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Peripheral neuropathies and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Ganglioside mimicry and peripheral nerve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Anti-ganglioside antibodies and clinical outcome of patients with Guillain-Barré Syndrome in northeast Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Glial fibrillary acidic protein in Guillain-Barré syndrome: Methodological issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Long term outcome after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Moderate and severe traumatic brain injury in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Traumatic brain injuries in a well-defined population: epidemiological aspects and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Mild traumatic brain injury in U.S. Soldiers returning from Iraq.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Predictive value of initial computerized tomography scan, intracranial pressure, and state of autoregulation in patients with traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Relationship of "dose" of intracranial hypertension to outcome in severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Use of somatosensory-evoked potentials and cognitive event-related potentials in predicting outcomes of patients with severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Review of the use of somatosensory evoked potentials in the prediction of outcome after severe brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Neuron-specific enolase as an aid to outcome prediction in head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Effects of head and extracranial injuries on serum protein S100B levels in trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

The prognostic value of the temporal course of S100beta protein in post-acute severe brain injury: A prospective and observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Tau proteins in serum predict outcome after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Temporal Alterations in Cerebrospinal Fluid Amyloid β-Protein and Apolipoprotein E After Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Spectrin breakdown products in the cerebrospinal fluid in severe head injury--preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Detectable levels of cytochrome C and activated caspase-9 in cerebrospinal fluid after human traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Axonal pathology in subarachnoid and intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

21 January 2018

Subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Prevalence and risk of rupture of intracranial aneurysms: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

The diagnosis of subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Spectrophotometry for Xanthochromia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Lifetime cost of stroke in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

CSF -neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Axonal damage and outcome in subarachnoid haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Serum neuron-specific enolase levels after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Clinical practice. Acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S100B in brain damage and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Copeptin: a novel, independent prognostic marker in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Neurofilament ELISA validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Combining laser capture microdissection and proteomics: Methodologies and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Cerebrospinal fluid ATP metabolites in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

The value of the serum neurofilament protein heavy chain as a biomarker for peri-operative brain injury after carotid endarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Prognostic Value of Copeptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

DETECTION OF CASPASE-3, NEURON SPECIFIC ENOLASE, AND HIGH-AENSITIVITY C-REACTIVE PROTEIN LEVELS IN BOTH CEREBROSPINAL FLUID AND SERUM OF PATIENTS AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.578624

10.1517/17530059.2011.578624

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23484553%20AND%20SRC:MED&resulttype=core&format=json